These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6413340)

  • 1. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilators in left ventricular failure.
    Camerini F; Mestroni L; Neri R; Humar F
    G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydralazine in chronic CHF.
    Chatterjee K; Rouleau JL; Massie BM
    Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
    Kittleson MD; Johnson LE; Oliver NB
    J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of a combination of theophylline and ethylenediamine in heart failure with pulmonary hypertension].
    Klein W
    Arzneimittelforschung; 1969 Sep; 19(9):1559-62. PubMed ID: 5394532
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasodilator therapy in heart failure (author's transl)].
    Kimata S
    Kokyu To Junkan; 1978 Sep; 26(9):863-72. PubMed ID: 100840
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral hydralazine on rest and exercise hemodynamics in patients with aortic or mitral regurgitation and left ventricular dysfunction.
    Slosky DA; Hindman MC; Peter RH; Wallace AG
    Clin Cardiol; 1981; 4(4):162-7. PubMed ID: 7273499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
    Beekman RH; Rocchini AP; Dick M; Crowley DC; Rosenthal A
    Pediatrics; 1984 Jan; 73(1):43-51. PubMed ID: 6361679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M; Gorlin R
    N Engl J Med; 1982 Jan; 306(2):57-62. PubMed ID: 7053487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indices of central hemodynamics in congestive heart failure caused by heart valve lesions and its treatment with arteriolar and arteriovenous vasodilators].
    Marshutin NA
    Revmatologiia (Mosk); 1984; (2):57-61. PubMed ID: 6382548
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
    Chatterjee K; Ports TA; Brundage BH; Massie B; Holly AN; Parmley WW
    Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afterload reduction with hydralazine following valve replacement.
    Marco JD; Standeven JW; Barner HB
    J Thorac Cardiovasc Surg; 1980 Jul; 80(1):50-3. PubMed ID: 7382535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions.
    Yadav R; Bhargava B; Aggarwal R; Narang R; Chopra A; Sapra R; Manchanda SC
    Indian Heart J; 1998; 50(2):173-8. PubMed ID: 9622984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of vasodilator therapy in acute and chronic valvular regurgitation.
    Greenberg BH; Rahimtoola SH
    Curr Probl Cardiol; 1984 Jul; 9(4):1-46. PubMed ID: 6744937
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
    Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
    Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.